270
Views
8
CrossRef citations to date
0
Altmetric
Research Article

The relevance of hypothalamus-pituitary-adrenocortical axis-related hormones to the cochlear symptoms in Ménière's disease

, , , , , & show all
Pages 897-904 | Received 22 Feb 2011, Accepted 11 Jul 2011, Published online: 15 Sep 2011

References

  • American Academy of Otolaryngology-Head and Neck Committee on Hearing and Equilibrium, 1995. Guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg, 113, 181–185.
  • Al-Mana D., Ceranic B., Djahanbakhch O. & Luxon L.M. 2008. Hormones and the auditory system: A review of physiology and pathophysiology. Neuroscience, 153, 881–900.
  • Aoki M., Ando K., Kuze B., Mizuta K., Hayashi T. . 2005. The association of antidiuretic hormone levels with an attack of Ménière's disease. Clin Otolaryngol, 30, 521–525.
  • Aoki M., Hayashi H., Kuze B., Mizuta K. & Ito Y. 2010. The association of the plasma vasopressin level during attacks with a prognosis of Ménière's disease. Int J Audiol, 49, 1–6.
  • Axelson D.A., Doraiswamy P.M., McDonald W.M., Boyko O.B., Tupler L.A. . 1993. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res, 47, 163–173.
  • Bastianetto S., Ramassamy C., Poirier J. & Quirion R. 1999. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res, 66, 35–41.
  • Blauer K.L., Poth M., Rogers W.M. & Bernton E.W. 1991. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology, 129, 3174–3179.
  • Crocetti A., Forti S., Ambrosetti U. & Bo L.D. 2009. Questionnaires to evaluate anxiety and depressive levels in tinnitus patients. Otolaryngol Head Neck Surg, 140, 403–405.
  • Fehm-Wolfsdorf G., Soherr U., Arndt R., Kern W., Fehm H.L. . 1993. Auditory reflex thresholds elevated by stress-induced cortisol secretion. Psychoneuroendocrinology, 18, 579–589.
  • Freeman M.E., Kanyicska B., Lerant A. & Nagy G. 2000. Prolactin: Structure, function, and regulation of secretion. Physiol Rev, 80, 1523–1631.
  • Green J.D. Jr., Blum D.J. & Harner S.G. 1991. Longitudinal follow-up of patients with Ménière's disease. Otolaryngol Head Neck Surg, 104, 783–788.
  • Horner K.C. 2003. The emotional ear in stress. Neurosci Biobehav Rev, 27, 437–446.
  • Horner K.C. & Cazals Y. 2003. Stress in hearing and balance in Ménière's disease. Noise Health, 5, 29–34.
  • Horner K.C., Guieu R., Magnan J., Chays A. & Cazals Y. 2002. Prolactinoma in some Ménière's patients: Is stress involved? Neuropsychopharmacology, 26, 135–138.
  • Ichimiya I., Adams J.C. & Kimura R.S. 1994. Changes in immunostaining of cochleas with experimentally induced endolymphatic hydrops. Ann Otol Rhinol Laryngol, 103, 457–468.
  • Jacobson G.P. & Newman C.W. 1990. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg, 116, 424–427.
  • Katsarkas A. 1996. Hearing loss and vestibular dysfunction in Ménière's disease. Acta Otolaryngol, 116, 185–188.
  • Kitahara T., Doi K., Maekawa C., Kizawa K., Horii A. . 2008. Ménière's attacks occur in the inner ear with excessive vasopressin type-2 receptors. J Neuroendocrinol, 20, 1295–1300.
  • Langguth B., Kleinjung T., Fischer B., Hajak G., Eichhammer P. . 2007. Tinnitus severity, depression, and the big five personality traits. Prog Brain Res, 166, 221–225.
  • Liapi C. & Chrousos G.P. 1992. Glucocorticoids. In: S.J. Jaffe & J.V. Aranda Pediatric Pharamacology, 2nd. Philadelphia: WB Saunders Co., 466–475.
  • McEwen B.S. 2000. The neurobiology of stress: From serendipity to clinical relevance. Brain Res, 886, 172–189.
  • Newman C.W., Sandridge S.A. & Jacobson G.P. 1998. Psychometric adequacy of the Tinnitus Handicap Inventory (THI) for evaluating treatment outcome. J Am Acad Audiol, 9, 153–160.
  • Ohashi M., Kato K., Nawata H. & Ibayashi H. 1986. Adrenocortical responsiveness to graded ACTH infusions in normal young and elderly human subjects. Gerontology, 32, 43–51.
  • Paparella M.M. 1985. The cause (multifactorial inheritance) and pathogenesis (endolymphatic malabsorption) of Ménière's disease and its symptoms (mechanical and chemical). Acta Otolaryngol, 99, 445–451.
  • Rarey K.E. & Luttge W.G. 1989. Presence of type I and type II/IB receptors for adrenocorticosteroid hormones in the inner ear. Hear Res, 41, 217–221.
  • Rarey K.E., Gerhardt K.J., Curtis L.M. & ten Cate W.J. 1995. Effect of stress on cochlear glucocorticoid protein: Acoustic stress. Hear Res, 82, 135–138.
  • Rosenfeld R.S., Hellman L., Roffwarg H., Weitzman E.D., Fukushima D.K. . 1971. Dehydroisoandrosterone is secreted episodically and synchronously with cortisol by normal man. J Clin Endocrinol Metab, 33, 87–92.
  • Savastano M., Maron M.B., Mangialaio M., Longhi P. & Rizzardo R. 1996. Illness behaviour, personality traits, anxiety, and depression in patients with Ménière's disease. J Otolaryngol, 25, 329–333.
  • Silverstein H., Isaacson J.E., Olds M.J., Rowan P.T. & Rosenberg S. 1998. Dexamethasone inner ear perfusion for the treatment of Ménière's disease: A prospective, randomized, double-blind, crossover trial. Am J Otol, 19, 196–201.
  • Spandow O., Hellstrom S. & Anniko M. 1988. Impaired hearing following instillation of hydrocortisone into the middle ear. Preliminary report from an animal study. Acta Otolaryngol Suppl, 455, 90–93.
  • Stahle J. 1976. Advanced Ménière's disease. A study of 356 severely disabled patients. Acta Otolaryngol, 81, 113–119.
  • Stahle J., Friberg U. & Svedberg A. 1991. Long-term progression of Ménière's disease. Acta Otolaryngol Suppl, 485, 78–83.
  • Tabuchi K., Murashita H., Tobita T., Oikawa K., Tsuji S. . 2005. Dehydroepiandrosterone sulfate reduces acoustic injury of the guinea-pig cochlea. J Pharmacol Sci, 99, 191–194.
  • Tabuchi K., Oikawa K., Uemaetomari I., Tsuji S., Wada T. . 2003. Glucocorticoids and dehydroepiandrosterone sulfate ameliorate ischemia-induced injury of the cochlea. Hear Res, 180, 51–56.
  • Takeda T., Kakigi A. & Saito H. 1995. Antidiuretic hormone (ADH) and endolymphatic hydrops. Acta Otolaryngol Suppl, 519, 219–222.
  • van Cruijsen N., Dullaart R.P., Wit H.P. & Albers F.W. 2005. Analysis of cortisol and other stress-related hormones in patients with Ménière's disease. Otol Neurotol, 26, 1214–1219.
  • van Cruijsen N., Jaspers J.P., van de Wiel H.B., Wit H.P. & Albers F.W. 2006. Psychological assessment of patients with Ménière's disease. Int J Audiol, 45, 496–502.
  • Vernon J., Johnson R. & Schleuning A. 1980. The characteristics and natural history of tinnitus in Ménière's disease. Otolaryngol Clin North Am, 13, 611–619.
  • Webster J.C. & Cidlowski J.A. 1994. Downregulation of the glucocorticoid receptor. A mechanism for physiological adaptation to hormones. Ann NY Acad Sci, 746, 216–220.
  • Wolkowitz O.M., Epel E.S. & Reus V.I. 2001. Stress hormone-related psychopathology: Pathophysiological and treatment implications. World J Biol Psychiatry, 2, 115–143.
  • Zoger S., Svedlund J. & Holgers K.M. 2006. Relationship between tinnitus severity and psychiatric disorders. Psychosomatics, 47, 282–288.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.